Open access
Sep 2026
Outcomes of As-Needed Aflibercept Treatment After Complete Regression in Polypoidal Choroidal Vasculopathy.
Half of the eyes with PCV achieved complete polypoidal regression remained quiescent after treatment deferral, whereas the remainder recurred, and posttreatment OCT biomarkers may help identify eyes that could benefit from continued treatment instead of PRN management.
V. Chaikitmongkol, Pawinee Boonyot, D. Patikulsila et al.
· JAMA ophthalmology · 0 citations